ADC Therapeutics(ADCT) - 2023 Q2 - Quarterly Report

Exhibit 99.1 Unaudited IFRS Condensed Consolidated Interim Financial Statements as of and for the three and six months ended June 30, 2023. Condensed Consolidated Interim Statement of Operations 2 Condensed Consolidated Interim Statement of Comprehensive Loss 3 Condensed Consolidated Interim Balance Sheet 4 Condensed Consolidated Interim Statement of Changes in Equity 5 Condensed Consolidated Interim Statement of Cash Flows 7 Notes to the Condensed Consolidated Interim Financial Statements 8 ADC Therapeutic ...